Welcome to our dedicated page for Ingersoll-Rand news (Ticker: IR), a resource for investors and traders seeking the latest updates and insights on Ingersoll-Rand stock.
Ingersoll Rand Inc. reports developments tied to its mission-critical flow creation, life science and industrial solutions portfolio. Company news commonly covers operating results, order and revenue trends, segment performance, and regular capital-return actions such as cash dividends.
Updates also include bolt-on acquisitions that expand technologies within areas such as metering and dosing, compression, blower and vacuum, and fluid management. Recent acquisition activity added hydropneumatic accumulators, pulsation dampeners, calibration pots and instrumentation to the Precision and Science Technologies segment. Other recurring announcements address sustainability recognition, investor conference participation, governance matters and business outlook commentary.
Ultima Genomics, a developer of an innovative ultra-high throughput sequencing architecture, announced the addition of Mark Stevenson, a seasoned executive with over 30 years of experience in the life sciences sector, to its Board of Directors. Stevenson, the former Executive Vice President and COO of Thermo Fisher Scientific, brings valuable expertise in next-generation sequencing technologies and innovation. His appointment is expected to bolster Ultima Genomics' position in the genomics and healthcare fields.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.